According to the 2025 ADA Standards of Care, which of the following nutrition behaviors are strongly encouraged for individuals with diabetes?
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
Announcements
_________________________
Upcoming Programs
___________________________
February is all about love, 💙 and that spirit shines brightly in diabetes care and education! We speak from the heart as we advocate for evidence-based care that supports well-being and transforms lives.
In recognition of these daily contributions of diabetes care and education specialists, we are delighted to announce our annual “Spreading the Love” Sale! Enjoy 20% off all our online courses, including program extensions through February 16th.
This month’s newsletter includes exciting information on a new “front-of-package” food labeling proposal that aims to provide more accurate and accessible information for consumers, before adding packaged foods to their carts.
We announce the approval of semaglutide as a first-line agent to protect renal function in people living with chronic kidney disease.
Have you ever considered volunteering at a diabetes camp? After reading this article contributed by a camper and later a diabetes nurse educator, you might be inspired to sign up for a camp near you.
DiabetesEd Services is thrilled to announce an exciting milestone—our first-ever offering of 14 Scholarships for healthcare professionals dedicated to serving under-resourced communities. This initiative is part of our Bridge Program, aimed at mentoring 1,000 new diabetes care professionals over the next ten years.
As always, test your knowledge with our Question and Rationale of the week. We hope to see you at our 3-Day Virtual DiabetesEd Training Conference in April or at a future event!
With love,
Coach Beverly, Bryanna, Tiffany, Christine, Andrew & Katarina
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on what defines overbasalization according to 2025 ADA Standards? 60% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
According to ADA 2025 Standards, more intensive preventive approaches should be considered in individuals who are at particularly high risk of progression to diabetes, including individuals with BMI ≥35 kg/m2 who:
Answer Choices:
Answer 1 is incorrect. 25% chose this answer, “Sit more than eight hours a day and have a sedentary lifestyle”. Although the ADA Standards recommend getting up and moving every half-hour, they don’t specify that eight hours of sitting a day qualifies a person as higher risk to progressing to diabetes.
Answer 2 is incorrect. 7% of you chose this answer “Have a history of thyroid or celiac disease”. These autoimmune conditions are more closely associated with immune mediated type 1 diabetes and do not place a person as higher risk for progression to type 2 diabetes.
Answer 3 is incorrect. About 9% of respondents chose this, “Consume a diet with high amounts of simple carbohydrates.” While eating foods rich in fiber and a variety of nutrients is important to decrease risk of diabetes, the ADA does not state that eating simple carbohydrates puts individuals in a higher risk category of progressing to diabetes.
Finally, Answer 4 is correct 60% chose this answer, “Have fasting plasma glucose of 110–125 or A1C ≥6.0%.” Great job. This is the BEST answer. According to ADA 2025 Standards, “More intensive preventive approaches should be considered in individuals who are at particularly high risk of progression to diabetes, including individuals with BMI ≥35 kg/m2, those at higher glucose levels (e.g., fasting plasma glucose 110–125 mg/dL [6.1–6.9 mmol/L], 2-h post challenge glucose 173–199 mg/dL [9.6–11.0 mmol/L], and A1C ≥6.0% [≥42 mmol/mol]), and individuals with a history of gestational diabetes mellitus.”
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
by Jeannie Hickey, RN, CDE
In 1965, when I was just 12 years old, my parents dropped me off at Bearskin Meadows, a two-week camp for kids with Type 1 diabetes. It was shortly after I had been diagnosed, and I was still adjusting to my new reality. I remember the daily routines vividly—carrying my cup of urine to the “lab,” lining up for my Regular and NPH injections twice a day, and using meal cards that followed the exchange system for servings.
But even with all that, there were moments of pure joy. I recall playing, singing around the campfire, and yes—roasting marshmallows for s’mores! (A sugary snack at a diabetes camp? Go figure!)
By the time I returned home, I felt much more comfortable with my condition and, more importantly, I felt hopeful. That experience gave me a sense of community and confidence that would shape my relationship with diabetes for years to come.
Fast forward 35 years. Now a Registered Nurse and Certified Diabetes Educator (RN, CDE), I found myself at a “Back to School” conference for parents of children with Type 1 diabetes, hosted by Diabetes Youth Families (DYF). During the event, camp counselors were leading the kids’ activities, and I recognized familiar images from the very same camp I had attended as a child. They invited me to return as a volunteer RN, offering insulin dose adjustments for a group of campers and helping with daily education alongside endocrinologists and other diabetes professionals. (And yes, there were CEUs too!)
That opportunity was life-changing. What started as a one-time volunteer experience quickly turned into a 21-year, part-time summer job. From my initial role as a volunteer, I eventually became the Assistant Medical Director, overseeing the medical care for kids, teens, and families during the two-month camp season. The work I did with Diabetes Youth Families was incredibly rewarding, and I continue to be inspired by the campers and their families each year.
I am thrilled to share my story and encourage you to consider signing up for this unique opportunity of volunteering at T1D camp. You get to learn about and support kids navigating type 1 while diabetes while they are having fun at camp.
Many states have camps, both independent, ADA, or through the Lions. Some offer state CEUs for your volunteer hours and the medical education presented by MDs, other RNs, RDs or Mental Health. DECA – Diabetes Education & Camping Association has a list of accredited camps to consider.
Jeannie Hickey RN, CDE (past Asst Med Dir for Bearskin Meadow Camp through Diabetes Youth Families)
T1D 60 yrs this July!!
If this is an experience you’d like to explore, there are many accredited camps and conferences available. Check out resources like Diabetes Youth Families to find a camp near you and make lasting connections with others living with Type 1 diabetes. Teen Ed Day Sponsorship Packet
While volunteering at camp your learning objectives are:
If new to camp, you will be partnered with a physician or RN until you feel comfortable with the protocol. There will be pump savvy RNs to support & assist your learning. You will not be on your own.
You can also support your Families by learning more about camp and encouraging them to attend as a family, or send their kids (and get a week free from diabetes). See the helpful resources below.
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
Adults with diabetes are at increased risk for the development of asymptomatic or symptomatic heart failure.
According to the ADA 2025 Standards of care, what action is needed to facilitate prevention of heart failure?
Ready for your certification exams? Our Level 3 course series is the final step in your exam prep, complementing our Level 1, 2, or 4 bundles. Designed for healthcare professionals preparing for diabetes certification exams in 3-6 months, this master-level series covers key topics like pharmacology, technology, MNT, and person-centered care, all based on the latest ADA Standards of Care.
Each course includes a video, podcast, practice test, and additional resources—available immediately for one full year. Boost your knowledge and confidence to succeed in your certification!
Given my seven-time experience taking the CDCES exam, I can say with complete conviction that being familiar with the American Diabetes Association (ADA) Standards of Care is one of the most important and essential strategies to prepare for exam success. More importantly, this evidence-based guidebook is crucial for providing the best clinical and person-centered care, with close attention to the Social Determinants of Health.
If you are taking the exam in January or February 2025 and you have already read the 2024 ADA Standards cover-to-cover, you are all set. It takes at least a year for the exam writers to include new questions culled from the ADA Standards. Having said that, if there are any critical new guidelines that impact clinical care, education, or treatment of diabetes, that content can be included in the exam that same year. From my review of the 2025 Standards, there are no critical new clinical guidelines that need immediate adoption into practice. One important caveat to consider: if you are relying on last year’s standards, make sure to read through the Summary of Revisions section included in the Standard of Care, so that you that latest information under your belt.
On the other hand, if you are taking the exam in 2025 and haven’t reviewed the ADA Standards in the past, I recommend a thorough review of the most recent ADA Standards. You can access the ADA Standards on our CDCES Coach App and the ADA Website at www.diabetes.org.
In case of emergency, there is a shorter version of the ADA Standards called the Abridged version for Primary Care Providers that highlights critical clinical content. The abridged version is usually released in February by the ADA. It can also be used as a quick review after you have read the document in full. Again, after successfully passing the exam seven times, my advice is to be familiar with the ADA Standards of Care in its entirety.
Below is an excerpt from the CBDCE Exam Handbook regarding what hours count towards this 1000-hour DSME requirement:
To help you keep track of your hours, we created the Diabetes Management Hours Tracker. The column “Remaining Hours Needed” is a formula that is tied to “Hours Completed” so be sure to only put numbers in the hour’s column so the formula automatically deducts those hours to get the remaining hours you need. Make sure you let your supervisor know you are tracking your hours, since they will need to attest and verify DSME hours completed.
Tracking your activities and hours consistently is key and this Hours Tracker excel sheet can help you tally your hours, while working toward your goal of becoming a CDCES.
Meeting the 1,000-hour requirement for the Certified Diabetes Care and Education Specialist (CDCES) exam is achievable with a variety of approaches. The hours needed can include volunteer or paid hours. Below are some practical ways to accumulate hours if you are not able to accrue enough hours in your current work environment.
As part of our Bridge Program, Coach Beverly wants to support YOUR efforts to mentor a new generation of Diabetes Care and Education Specialists. If you are a mentor, we are offering significant discounts off of our Diabetes Boot Camp or Virtual 3 Day Program for groups of mentees who are practicing in underserved regions of our country. Please email us for more information at [email protected]
This webinar provides a comprehensive breakdown of the ADA Standards of Care, focusing on essential content for clinical practice and exam success.
This webinar is designed for healthcare professionals aiming to deepen their understanding of the ADA Standards for improved practice or preparing for the BC-ADM or CDCES certification exams.
Last month, the U.S. Food and Drug Administration (FDA) approved Ozempic (semaglutide) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular-related death in adults with type 2 diabetes and chronic kidney disease (CKD). This decision was based on results from the FLOW phase 3 clinical trial.
This expanded approval represents a major advancement for people managing both conditions, offering an additional tool to protect kidney function and heart health.
Chronic kidney disease (CKD) is a serious and prevalent condition affecting about 30% of people living with diabetes. CKD can progress over time, potentially leading to kidney failure that requires dialysis or a transplant. Additionally, individuals with both CKD and diabetes face an elevated risk of cardiovascular complications, including heart attacks and strokes.
Semaglutide (Ozempic) is a commonly used GLP-1, that not only lowers blood glucose levels and body weight, it has also been proven to reduce the risk of major cardiovascular events in adults with type 2 diabetes.
Now, with this latest FDA approval, semaglutide is also recognized for its ability to slow kidney disease progression and lower the risk of kidney failure and cardiovascular-related deaths in people with type 2 diabetes and CKD.
The FDA’s decision was based on the FLOW phase 3b kidney outcomes trial, which involved 3,533 adults with type 2 diabetes and CKD. The study compared the effects of once-weekly semaglutide 1.0 mg injections versus a placebo. Findings revealed a 24% reduction in the risk of kidney disease worsening, kidney failure, and cardiovascular death in participants receiving semaglutide. Due to the overwhelming efficacy, the trial was stopped early after meeting its pre-specified criteria.
Dr. Richard E. Pratley, Medical Director at the AdventHealth Diabetes Institute in Orlando, FL, and Co-Chair of the FLOW Trial, emphasized the significance of this approval:
“Managing type 2 diabetes is already challenging, and chronic kidney disease adds another layer of complexity. In my practice, I see many patients with serious kidney complications—some requiring dialysis. The FDA’s decision provides new hope and an additional treatment option that can make a meaningful difference in protecting kidney function and cardiovascular health.”
For individuals living with both type 2 diabetes and CKD, semaglutide offers a new treatment option to help preserve kidney function and lower the risk of life-threatening cardiovascular events. Effectively managing both conditions can improve long-term health outcomes and quality of life.
If you are working with individuals with type 2 diabetes and CKD, initiating semaglutide early in the treatment plan can not only protect kidney health but also decrease the risk of worsening kidney function, further improving outcomes.
The FDA’s expanded approval of Ozempic marks a crucial milestone for people with type 2 diabetes and CKD. With strong clinical trial evidence supporting its effectiveness, this treatment provides renewed hope for those at risk of worsening kidney disease and cardiovascular complications.
See our Medication PocketCards for more information.
NEJM Article: Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Gain fresh insights, practical tools, and a deeper understanding of the latest in person-centered diabetes care. Our expert team brings the ADA Standards of Care to life—covering medications, behavior change, technology, and more! If you’re preparing for the CDCES or BC-ADM exam, this conference—paired with free bonus courses—serves as the ideal study companion!
With interactive co-teaching, we keep sessions engaging, relevant, and fun. Let’s learn and grow together!
Our expert team transforms complex diabetes science into clear, practical insights—keeping it real, engaging, and fun! The faculty includes:
For last week’s practice question, we quizzed participants on what defines overbasalization according to 2025 ADA Standards?. 52% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question:
What defines overbasalization according to 2025 ADA Standards?
According to the new 2025 ADA Standards of Care, which of the following most accurately reflects overbasalization?
Answer Choices:
Answer 1 is incorrect. 25% chose this answer: basal insulin doses exceeding 0.5 units/kg/day. This year, the ADA Recommendation was revised to remove consideration of basal insulin doses exceeding 0.5 units/kg/day as evidence of overbasalization. Instead, signs of overbasalization including significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability should be used.
Answer 2 is correct. 52% of you chose this answer: significant bedtime-to-morning or postprandial-to-preprandial glucose differential. GREAT JOB! In the 2025 ADA Standards (9), they define overbasalization as significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability.
Answer 3 is incorrect. About 18% of respondents chose this: low glycemic variability, This is a juicy and tempting answer. However, high glycemic variability (lots of ups and downs) is more closely associated with hypoglycemia.
Finally, Answer 4 is incorrect 3% chose this answer: basal insulin dose exceeding 50 units twice per day. Overbasalization is not defined by the amount of insulin used, but by the glucose response including significant bedtime-to-morning or postprandial-to-preprandial glucose differential, occurrences of hypoglycemia (aware or unaware), and high glycemic variability
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Ready for your certification exams? Our Level 3 course series is the final step in your exam prep, complementing our Level 1, 2, or 4 bundles. Designed for healthcare professionals preparing for diabetes certification exams in 3-6 months, this master-level series covers key topics like pharmacology, technology, MNT, and person-centered care, all based on the latest ADA Standards of Care.
Each course includes a video, podcast, practice test, and additional resources—available immediately for one full year. Boost your knowledge and confidence to succeed in your certification!
[yikes-mailchimp form="1"]
Diabetes Education Services offers education and training to diabetes educators in the areas of both Type 1 and Type 2 Diabetes for the novice to the established professional. Whether you are training to be a Certified Diabetes Care and Education Specialist (CDCES), practicing at an advanced level and interested in board certification, or a health care professional and/or Certified Diabetes Care and Education Specialist (CDCES) who needs continuing education hours to renew your license or CDCES, we have diabetes education information, resources and training; learning and teaching tools; and diabetes online courses available for continuing education (CE). Read our disclaimer for full disclosure.